Extended Efficacy of Once-Daily Atomoxetine in ADHD
The efficacy of atomoxetine administered once daily (final dose 1.3 +/- 0.3 mg/kg; mean 44.5 mg per day; range 10-80 mg per day) in the morning was assessed throughout the day, including evening and early morning, in a total of 197 children, 6 to 12 years of age (71% male), diagnosed with attention-...
Saved in:
Main Author: | J Gordon Millichap (Author) |
---|---|
Format: | Book |
Published: |
Pediatric Neurology Briefs Publishers,
2004-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Controlled Study of Atomoxetine in ADHD
by: J Gordon Millichap
Published: (2011) -
Atomoxetine Open-Label Trial in ADHD
by: J Gordon Millichap
Published: (2002) -
Effects of Methylphenidate and Atomoxetine on Cortical Inhibition in ADHD
by: J Gordon Millichap
Published: (2006) -
Once-daily medications for the pharmacological management of ADHD in adults
by: Oleg v Tcheremissine, et al.
Published: (2009) -
Morning and evening behavior in children and adolescents treated with atomoxetine once daily for Attention-Deficit/Hyperactivity Disorder (ADHD): Findings from two 24-week, open-label studies
by: Schacht Alexander, et al.
Published: (2009)